Morningstar
•
Aug 12, 2026
Stevanato Group S.p.A.: Stevanato: Initiating Coverage With a Narrow Moat and USD 21.10 FVE; Shares Fairly Valued
Summary
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
ZWS: Lowering target price to $51.00
Sep 02, 2026
•
ZWS
HAYW: Lowering target price to $15.00
Sep 02, 2026
•
HAYW
WST: Lowering target price to $373.00
Sep 02, 2026
•
WST
AZTA: Lowering target price to $33.00
Sep 02, 2026
•
AZTA
NVST: Lowering target price to $28.00
Sep 02, 2026
•
NVST
